Company / Free Cash Flow per Share
AIM ImmunoTech Inc. Free Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.43
FY2024
5-year range
-$0.43 / -$0.25
FY2020-FY2024
Trend
-28.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has declined for 3 consecutive years, from $-0.25 in FY2021 to $-0.43 in FY2024.
Based on SEC 10-K filings.
-0.43 in FY2024.
Declined from $-0.29 to $-0.43 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s free cash flow per share has declined for 3 consecutive years.
- In FY2024, free cash flow per share decreased 28.7% year-over-year.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$0.43 | -28.7% |
| FY2023 | -$0.34 | -15.4% |
| FY2022 | -$0.29 | -18.4% |
| FY2021 | -$0.25 | +75.4% |
| FY2020 | -$1.00 | +87.9% |
| FY2019 | -$8.25 | -2436.9% |
| FY2018 | -$0.33 | +51.7% |
| FY2017 | -$0.67 | -84.2% |
| FY2016 | -$0.37 | -357.6% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026